Cargando…
Tripartite motif 32 prevents pathological cardiac hypertrophy
TRIM32 (tripartite motif 32) is widely accepted to be an E3 ligase that interacts with and eventually ubiquitylates multiple substrates. TRIM32 mutants have been associated with LGMD-2H (limb girdle muscular dystrophy 2H). However, whether TRIM32 is involved in cardiac hypertrophy induced by biomech...
Autores principales: | Chen, Lijuan, Huang, Jia, Ji, Yanxiao, Zhang, Xiaojing, Wang, Pixiao, Deng, Keqiong, Jiang, Xi, Ma, Genshan, Li, Hongliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847158/ https://www.ncbi.nlm.nih.gov/pubmed/26884348 http://dx.doi.org/10.1042/CS20150619 |
Ejemplares similares
-
Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway
por: Yang, Hui, et al.
Publicado: (2020) -
Tripartite Motif-Containing Protein 32 (TRIM32): What Does It Do for Skeletal Muscle?
por: Jeong, Seung Yeon, et al.
Publicado: (2023) -
Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways
por: Chen, Yan, et al.
Publicado: (2022) -
Tripartite motif 38 attenuates cardiac fibrosis after myocardial infarction by suppressing TAK1 activation via TAB2/3 degradation
por: Lu, Zhengri, et al.
Publicado: (2022) -
Tripartite motif 38 alleviates the pathological process of NAFLD–NASH by promoting TAB2 degradation
por: Yao, Xinxin, et al.
Publicado: (2023)